Group A for General Immune Health in Healthy Subjects

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
NIS Labs, Klamath Falls, OR
General Immune Health in Healthy Subjects+1 More
Transfer factor from colostrum ultrafiltrate - DietarySupplement
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

Clinical-proof-of concept study, comparing the acute immune impacts of of 2 doses of a novel blend of supplements to a placebo. This study involves twenty-four participants, composed of healthy adults, who will be taking a placebo and 2 different doses of the blend at different times. Testing for immune status and cytokine levels will be conducted to determine the acute impact of the blend on immune function as compared to the placebo.

Eligible Conditions

  • General Immune Health in Healthy Subjects
  • Immune Surveillance

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for General Immune Health in Healthy Subjects

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: 2 hours

2 hours
Immune Surveillance and Alertness
Immune communication
Immune responsiveness

Trial Safety

Safety Progress

1 of 3

Other trials for General Immune Health in Healthy Subjects

Trial Design

2 Treatment Groups

Group A
1 of 2
Group B
1 of 2
Experimental Treatment

24 Total Participants · 2 Treatment Groups

Primary Treatment: Group A · No Placebo Group · N/A

Group A
DietarySupplement
Experimental Group · 1 Intervention: Transfer factor from colostrum ultrafiltrate · Intervention Types: DietarySupplement
Group B
DietarySupplement
Experimental Group · 1 Intervention: Transfer factor from colostrum ultrafiltrate · Intervention Types: DietarySupplement

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 2 hours
Closest Location: NIS Labs · Klamath Falls, OR
2016First Recorded Clinical Trial
1 TrialsResearching General Immune Health in Healthy Subjects
5 CompletedClinical Trials

Eligibility Criteria

Age 18+ · All Participants · 8 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are healthy.
You have veins that are easy to see in one or both arms.
You are willing to comply with study procedures, including those related to personal data protection.
You maintain a consistent diet and lifestyle throughout the study.
You are abstaining from coffee, tea, and soft drinks for at least one hour prior to a clinic visit.
You are not exercising on and nutritional supplements on the morning of a study visit.
You are not using any of the following: music, candy, gum, computer/cell phone use, during clinic visits.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.